相关实验视频

Updated: Jul 5, 2025

Histological Quantification of Chronic Myocardial Infarct in Rats

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

尿素与蛋白的比率预测了ST段升高心肌梗塞中腹腔动脉瘤的形成

Kai Zhang¹, Lihong Yang², Xiaoguang Wu¹

¹Heart Center of Henan Provincial People's Hospital, Central China Fuwai Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, Henan, China.

ESC heart failure

|January 18, 2024

概括

血尿素与白的比率 (BAR) 是一种重要的预测指标,用于预测ST段升高心肌梗塞 (STEMI) 患者在初级穿皮冠状动脉干预 (PCI) 后形成左心室动脉瘤 (LVA) 的情况. 较高的BARR水平表明LVA发展的风险增加.

科学领域:

心脏病学心脏病学
生物标志物生物标志物
肌肉心脏病发作肌肉心脏病发作

背景情况:

左心室动脉瘤 (LVA) 是急性心肌梗塞 (MI) 后的一个严重并发症.
确定LVA的预测标志物对于ST段升高心肌梗塞 (STEMI) 患者的风险分层和管理至关重要.

研究的目的:

评估血尿素与白蛋白比率 (BAR) 对LVA发展的预测值.
评估BAR作为STEMI患者接受初级皮肤穿透冠状动脉干预 (PCI) 的潜在生物标志物.

主要方法:

预计将有1123名接受初级PCI的STEMI患者进行招生.
在LVA和非LVA组之间比较临床和实验室数据.
多变量后勤回归和接收器操作特征 (ROC) 曲线分析以确定独立预测因素并评估预测能力.

主要成果:

在14.4%的患者中观察到LVA.
较高的BARR水平与LVA形成有显著的关联 (P<0.001).
BAR,左心室喷射分数 (LVEF) 和罪祸首左前下降动脉 (LAD) 是LVA的独立预测因素. 该BAR表现出一个显著的分辨力 (C-统计 = 0.723).

结论:

升高的BARR是初级PCI治疗的STEMI患者中LVA形成的独立预测因子.
与血液尿素或白的单个测量相比,BAR提供了更好的预测价值.
将BAR与LVEF和罪祸首船-LAD相结合,可以显著提高LVA预测.

关键词:

急性ST段升高心肌梗塞心肌梗塞血尿素与白的比率是血尿素与白的比率.左心室动脉瘤是什么意思预测性的预测性的主要的穿皮冠状动脉干预.

更多相关视频

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model

Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model

Published on: February 23, 2020

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...